- Dihydropteroate synthase inhibitor
-
A dihydropteroate synthetase inhibitor is a drug that inhibits the action of dihydropteroate synthetase. Most are sulfonamides.
In bacteria, antibacterial sulfonamides act as competitive inhibitors of the enzyme dihydropteroate synthetase, DHPS. DHPS catalyses the conversion of PABA (para-aminobenzoate) to dihydropteroate, a key step in folate synthesis. Folate is necessary for the cell to synthesize nucleic acids (nucleic acids are essential building blocks of DNA and RNA), and in its absence cells will be unable to divide. Hence the sulfonamide antibacterials exhibit a bacteriostatic rather than bactericidal effect.
Uses
Folate is not synthesized in mammalian cells, but is instead a dietary requirement. This explains the selective toxicity to bacterial cells of these drugs. These antibiotics are used to treat pneumocystis jiroveci pneumonia, urinary tract infections, and shigellosis.
References
Pharmacology: enzyme inhibition Class Substrate Oxidoreductase (EC 1)1.1 Aldose reductase · HMG-CoA reductase
1.13 Lipoxygenase
1.17 Xanthine oxidase · Ribonucleotide reductaseTransferase (EC 2)2.1 COMT · Thymidylate synthase
2.4 PARP
2.5 Dihydropteroate synthetase · Farnesyltransferase
2.6 GABA transaminase
2.7 Nucleotidyltransferase (Integrase, Reverse transcriptase) · Protein kinase (Tyrosine-kinase (Janus kinase))Hydrolase (EC 3)3.1 Phosphodiesterase · Acetylcholinesterase · Ribonuclease
3.2 Polygalacturonase · Neuraminidase · Alpha-glucosidase
3.4 Protease: Exopeptidase (Dipeptidyl peptidase-4, ACE) · Endopeptidase (Trypsin, Renin, Matrix metalloproteinase)
3.5 Histone deacetylase · Beta-lactamaseLyase (EC 4)4.1 Dopa decarboxylase
4.2 Carbonic anhydraseAntibacterials: nucleic acid inhibitors (J01E, J01M) Antifolates
(inhibits
purine metabolism,
thereby inhibiting
DNA and RNA synthesis)Sulfonamides
(DHPS inhibitor)Other/ungroupedCombinationsTopoisomerase
inhibitors/
quinolones/
(inhibits
DNA replication)1st g.2nd g.Ciprofloxacin# • Enoxacin‡ • Fleroxacin‡ • Lomefloxacin • Nadifloxacin • Ofloxacin • Norfloxacin • Pefloxacin • Rufloxacin3rd g.4th g.Besifloxacin • Clinafloxacin† • Garenoxacin • Gemifloxacin • Moxifloxacin • Gatifloxacin‡ • Sitafloxacin • Trovafloxacin‡/Alatrofloxacin‡ • PrulifloxacinVet.Related (DG)Anaerobic DNA
inhibitorsNitrofuran derivativesRNA synthesis #WHO-EM. ‡Withdrawn from market. Clinical trials: †Phase III. §Never to phase III Antiparasitics – antiprotozoal agents – Chromalveolate antiparasitics (P01) Alveo-
lateIndividual
agentsOtherDHFR inhibitors
(antifols)Sulfadoxine • sulfamethoxypyrazineCoformulationFansidar# (sulfadoxine/pyrimethamine)OtherCombi-
nationsFixed-dose (coformulated) ACTsartemether-lumefantrine#
artesunate-amodiaquine (ASAQ)
artesunate-mefloquine (ASMQ)
dihydroartemisinin-piperaquine
artesunate-pyronaridineOther combinations
(not co-formulated)artesunate/SP • artesunate/mefloquine •
quinine/tetracycline • quinine/doxycycline • quinine/clindamycinHetero-
kont#WHO-EM. ‡Withdrawn from market. Clinical trials: †Phase III. §Never to phase III Antimycobacterials, including tuberculosis treatment and leprostatic agents (J04) Nucleic acid inhibitor Antifolates/DSIASA4-Aminosalicylic acid# (Calcium aminosalicylate, Sodium aminosalicylate)Protein synthesis inhibitor Cell envelope antibiotic Peptidoglycan layerAlanine analogue: Cycloserine#Arabinogalactan layerEthylenediamine/arabinosyltransferase inhibitor: Ethambutol#
SQ109†Mycolic acid layerHydrazides/mycolic acid synth. inhibition: Isoniazid#
Thiocarbamides: Ethionamide# • Prothionamide • ThiocarlideOther/unknown phenazine (Clofazimine)# • pyrazine (Pyrazinamide#, Morinamide) • isoxazole (Terizidone) • R207910/TMC207†Combinations Rifampicin/isoniazid/pyrazinamide#WHO-EM. ‡Withdrawn from market. Clinical trials: †Phase III. §Never to phase III This antiinfective drug article is a stub. You can help Wikipedia by expanding it.